CollPlant Biotechnologies (CLGN) Competitors $2.80 -0.30 (-9.68%) Closing price 03:46 PM EasternExtended Trading$3.00 +0.20 (+7.11%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLGN vs. SGHT, ZJYL, KRMD, MGRM, INFU, TELA, HYPR, ZYXI, LUCD, and FONRShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Sight Sciences (SGHT), Jin Medical International (ZJYL), KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), InfuSystem (INFU), TELA Bio (TELA), Hyperfine (HYPR), Zynex (ZYXI), Lucid Diagnostics (LUCD), and FONAR (FONR). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. Sight Sciences Jin Medical International KORU Medical Systems Monogram Orthopaedics InfuSystem TELA Bio Hyperfine Zynex Lucid Diagnostics FONAR CollPlant Biotechnologies (NASDAQ:CLGN) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings. Which has better earnings and valuation, CLGN or SGHT? CollPlant Biotechnologies has higher earnings, but lower revenue than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than CollPlant Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollPlant Biotechnologies$650K49.34-$7.02M-$1.54-1.82Sight Sciences$79.87M1.73-$55.55M-$1.03-2.61 Does the MarketBeat Community favor CLGN or SGHT? CollPlant Biotechnologies received 120 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 59.83% of users gave CollPlant Biotechnologies an outperform vote while only 30.30% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformCollPlant BiotechnologiesOutperform Votes14059.83% Underperform Votes9440.17% Sight SciencesOutperform Votes2030.30% Underperform Votes4669.70% Which has more volatility and risk, CLGN or SGHT? CollPlant Biotechnologies has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500. Does the media prefer CLGN or SGHT? In the previous week, Sight Sciences had 1 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 2 mentions for Sight Sciences and 1 mentions for CollPlant Biotechnologies. Sight Sciences' average media sentiment score of 0.74 beat CollPlant Biotechnologies' score of 0.00 indicating that Sight Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CollPlant Biotechnologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sight Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CLGN or SGHT? CollPlant Biotechnologies currently has a consensus price target of $12.50, indicating a potential upside of 346.43%. Sight Sciences has a consensus price target of $3.83, indicating a potential upside of 42.50%. Given CollPlant Biotechnologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe CollPlant Biotechnologies is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Is CLGN or SGHT more profitable? Sight Sciences has a net margin of -63.30% compared to CollPlant Biotechnologies' net margin of -2,680.00%. Sight Sciences' return on equity of -47.28% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets CollPlant Biotechnologies-2,680.00% -77.05% -61.43% Sight Sciences -63.30%-47.28%-32.72% Do institutionals & insiders have more ownership in CLGN or SGHT? 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 9.6% of CollPlant Biotechnologies shares are owned by company insiders. Comparatively, 28.9% of Sight Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummarySight Sciences beats CollPlant Biotechnologies on 10 of the 18 factors compared between the two stocks. Remove Ads Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.07M$9.14B$5.68B$8.32BDividend YieldN/A1.41%4.55%4.02%P/E Ratio-1.8217.6724.5819.25Price / Sales49.3469.70395.7394.10Price / CashN/A19.6738.1634.64Price / Book1.135.657.064.46Net Income-$7.02M$284.66M$3.20B$247.07M7 Day Performance-10.83%2.29%1.49%3.06%1 Month Performance-17.98%-1.97%5.87%-2.85%1 Year Performance-46.67%-15.88%14.97%4.64% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies2.3048 of 5 stars$2.80-9.7%$12.50+346.4%-39.0%$32.07M$650,000.00-1.8270Upcoming EarningsHigh Trading VolumeSGHTSight Sciences3.1921 of 5 stars$2.78+2.2%$3.83+37.9%-40.3%$142.71M$79.87M-2.73210ZJYLJin Medical InternationalN/A$0.89+4.4%N/A-76.4%$139.14M$23.50M0.00245News CoveragePositive NewsGap DownKRMDKORU Medical Systems2.1658 of 5 stars$2.97+7.2%$4.70+58.2%+34.3%$136.14M$33.65M-11.8880MGRMMonogram Orthopaedics3.2092 of 5 stars$3.67+57.5%$4.00+9.0%+26.2%$129.51M$364,999.00-7.8128High Trading VolumeINFUInfuSystem1.913 of 5 stars$5.75+3.6%$13.00+126.1%N/A$120.80M$134.86M95.85410High Trading VolumeTELATELA Bio3.0479 of 5 stars$2.43+3.4%$9.25+280.7%-75.6%$95.71M$68.65M-1.44120Earnings ReportHYPRHyperfine3.4197 of 5 stars$1.28+39.3%$1.60+25.0%-17.8%$93.38M$13.26M-2.25190Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeZYXIZynex3.2989 of 5 stars$2.90-2.4%$10.25+253.4%-79.7%$92.55M$192.35M19.331,100News CoverageHigh Trading VolumeLUCDLucid Diagnostics2.2253 of 5 stars$1.47+5.8%$3.63+146.6%+37.6%$87.23M$4.19M-1.2970Analyst ForecastNews CoverageGap UpHigh Trading VolumeFONRFONAR2.319 of 5 stars$13.98+1.2%N/A-38.4%$86.72M$101.57M12.16480Positive News Remove Ads Related Companies and Tools Related Companies Sight Sciences Competitors Jin Medical International Competitors KORU Medical Systems Competitors Monogram Orthopaedics Competitors InfuSystem Competitors TELA Bio Competitors Hyperfine Competitors Zynex Competitors Lucid Diagnostics Competitors FONAR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLGN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLGN Stock Free CLGN Stock Alerts